New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 20, 2014
07:48 EDTAKBAAkebia 5.88M share IPO priced at $17.00
The deal size was increased to 5.88M shares from 4.9M shares and priced at the high-end of the $14.00-$17.00 range. Morgan Stanley, Credit Suisse and UBS acted as joint book running managers for the offering.
News For AKBA From The Last 14 Days
Check below for free stories on AKBA the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 11, 2014
07:01 EDTAKBAAkebia reports Q2 EPS (39c), two estimates (52c)
Subscribe for More Information
August 6, 2014
07:19 EDTAKBAAkebia names Brad Maroni as Chief Medical Officer
Akebia Therapeutics (AKBA) announced the expansion of its senior management team with three key additions: Brad Maroni, M.D., as Senior Vice President and Chief Medical Officer, Mark De Rosch, Ph.D., as Vice President of Regulatory Affairs and Tamara Dillon as Vice President of Human Resources. Maroni most recently served as Vice President, Medical Research at Biogen Idec (BIIB).

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use